UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (39652) 39652
Newspaper Article (1066) 1066
Book Chapter (555) 555
Newsletter (198) 198
Book / eBook (41) 41
Magazine Article (39) 39
Conference Proceeding (16) 16
Trade Publication Article (12) 12
Transcript (12) 12
Reference (9) 9
Dissertation (7) 7
Publication (7) 7
Government Document (3) 3
Web Resource (3) 3
Streaming Video (2) 2
Book Review (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (31861) 31861
science & technology (31376) 31376
life sciences & biomedicine (30442) 30442
chemotherapy (26176) 26176
female (23179) 23179
oncology (22112) 22112
middle aged (18023) 18023
cancer (17019) 17019
aged (15403) 15403
male (14639) 14639
adult (14185) 14185
antineoplastic combined chemotherapy protocols - therapeutic use (11101) 11101
treatment outcome (9934) 9934
chemotherapy, adjuvant (9051) 9051
tumors (8986) 8986
care and treatment (8185) 8185
breast cancer (8158) 8158
biological and medical sciences (8152) 8152
medical sciences (8119) 8119
antineoplastic combined chemotherapy protocols - adverse effects (7853) 7853
cancer therapies (7544) 7544
surgery (6987) 6987
breast neoplasms - drug therapy (6755) 6755
metastasis (6597) 6597
medicine & public health (6109) 6109
neoplasm staging (6041) 6041
patients (5858) 5858
research (5562) 5562
antineoplastic agents (5509) 5509
prognosis (5253) 5253
aged, 80 and over (5040) 5040
disease-free survival (4975) 4975
retrospective studies (4818) 4818
health aspects (4704) 4704
combined modality therapy (4617) 4617
analysis (4602) 4602
clinical trials (4557) 4557
pharmacology. drug treatments (4228) 4228
antineoplastic agents - therapeutic use (4156) 4156
radiotherapy (4123) 4123
risk factors (3987) 3987
radiation therapy (3753) 3753
antineoplastic agents - adverse effects (3749) 3749
survival rate (3664) 3664
survival analysis (3603) 3603
follow-up studies (3529) 3529
drug therapy (3490) 3490
breast neoplasms - pathology (3421) 3421
medical prognosis (3420) 3420
fluorouracil - administration & dosage (3406) 3406
colorectal cancer (3298) 3298
antineoplastic combined chemotherapy protocols - administration & dosage (3183) 3183
hematology, oncology and palliative medicine (2899) 2899
pharmacology & pharmacy (2821) 2821
survival (2811) 2811
quality of life (2734) 2734
drug administration schedule (2647) 2647
studies (2605) 2605
prospective studies (2604) 2604
cisplatin - administration & dosage (2591) 2591
time factors (2584) 2584
abridged index medicus (2519) 2519
toxicity (2519) 2519
adjuvant treatment (2452) 2452
oncology, experimental (2429) 2429
cancer patients (2353) 2353
adolescent (2298) 2298
animals (2283) 2283
medical research (2275) 2275
young adult (2250) 2250
patient outcomes (2232) 2232
neoadjuvant therapy (2215) 2215
immunotherapy (2164) 2164
antimitotic agents (2153) 2153
kaplan-meier estimate (2137) 2137
antineoplastic agents - administration & dosage (2084) 2084
metastases (2035) 2035
neoplasm metastasis (1995) 1995
deoxycytidine - analogs & derivatives (1976) 1976
radiotherapy, adjuvant (1915) 1915
cancer research (1905) 1905
fluorouracil - adverse effects (1905) 1905
hematology (1874) 1874
medicine (1816) 1816
usage (1815) 1815
lung cancer (1790) 1790
chemotherapy, adjuvant - adverse effects (1781) 1781
development and progression (1725) 1725
neoplasms. tumors. oncology. including cancer and carcinogens (1720) 1720
colorectal neoplasms - drug therapy (1718) 1718
research article (1689) 1689
gynecology. andrology. obstetrics (1659) 1659
mortality (1642) 1642
review (1641) 1641
dose-response relationship, drug (1638) 1638
randomized controlled trials as topic (1601) 1601
cyclophosphamide - administration & dosage (1573) 1573
multivariate analysis (1569) 1569
neoplasms - drug therapy (1545) 1545
cisplatin (1536) 1536
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (6) 6
Gerstein Science - Stacks (5) 5
Baycrest Hospital - Stacks (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Dentistry (Harry R Abbott) - Stacks (1) 1
Holland Bloorview Kids Rehabilitation - Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Online Resources - Online (1) 1
Scarborough Hospital - Hospital Department (1) 1
Scarborough Hospital - Online (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (40535) 40535
German (455) 455
Japanese (406) 406
French (219) 219
Russian (121) 121
Chinese (80) 80
Spanish (62) 62
Portuguese (51) 51
Italian (50) 50
Hungarian (46) 46
Polish (31) 31
Dutch (15) 15
Norwegian (14) 14
Czech (10) 10
Danish (9) 9
Turkish (8) 8
Romanian (7) 7
Hebrew (6) 6
Korean (5) 5
Bulgarian (2) 2
Finnish (2) 2
Icelandic (2) 2
Lithuanian (2) 2
Ukrainian (2) 2
Arabic (1) 1
Croatian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The lancet oncology, ISSN 1470-2045, 01/2018, Volume 19, Issue 1, pp. 139 - 148
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2017, Volume 389, Issue 10075, pp. 1195 - 1205
Journal Article
The New England journal of medicine, ISSN 0028-4793, 11/2017, Volume 377, Issue 19, pp. 1813 - 1823
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2017, Volume 389, Issue 10073, pp. 1011 - 1024
Journal Article
The New England journal of medicine, ISSN 0028-4793, 01/2015, Volume 372, Issue 5, pp. 436 - 446
Journal Article
The New England journal of medicine, ISSN 0028-4793, 07/2014, Volume 371, Issue 2, pp. 107 - 118
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Gynecology. Andrology. Obstetrics | Mammary gland diseases | General aspects | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Tumors | Estradiol - blood | Breast Neoplasms - surgery | Follow-Up Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antineoplastic Agents, Hormonal - adverse effects | Aromatase Inhibitors - adverse effects | Antineoplastic Agents, Hormonal - therapeutic use | Mastectomy | Adult | Female | Chemotherapy, Adjuvant | Aromatase Inhibitors - therapeutic use | Osteoporosis - chemically induced | Premenopause | Kaplan-Meier Estimate | Triptorelin Pamoate - adverse effects | Triptorelin Pamoate - therapeutic use | Breast Neoplasms - drug therapy | Disease-Free Survival | Breast Neoplasms - radiotherapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Tamoxifen - therapeutic use | Quality of Life | Androstadienes - therapeutic use | Tamoxifen - adverse effects | Androstadienes - adverse effects | Care and treatment | Breast cancer | Research | Ovariectomy | Invasiveness | Estrogens | Radiation | Clinical trials | Data processing | Pituitary (anterior) | Gonadotropins | Tamoxifen | Survival | Patients | Clinical outcomes | Post-menopause | Chemotherapy | Aromatase | Index Medicus | Abridged Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 04/2016, Volume 34, Issue 10, pp. 1034 - 1042
Journal Article
The lancet oncology, ISSN 1470-2045, 2015, Volume 16, Issue 13, pp. 1344 - 1354
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Catheter Ablation - mortality | South America | Carcinoma, Hepatocellular - mortality | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Hepatectomy - mortality | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | North America | Young Adult | Carcinoma, Hepatocellular - drug therapy | Time Factors | Aged, 80 and over | Liver Neoplasms - pathology | Catheter Ablation - adverse effects | Chemotherapy, Adjuvant | Europe | Risk Factors | Niacinamide - adverse effects | Niacinamide - therapeutic use | Disease Progression | New Zealand | Protein Kinase Inhibitors - administration & dosage | Intention to Treat Analysis | Niacinamide - analogs & derivatives | Liver Neoplasms - mortality | Antineoplastic Agents - adverse effects | Phenylurea Compounds - adverse effects | Adult | Female | Double-Blind Method | Hepatectomy - adverse effects | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Neoplasm Recurrence, Local | Phenylurea Compounds - therapeutic use | Carcinoma, Hepatocellular - surgery | Liver Neoplasms - surgery | Treatment Outcome | Niacinamide - administration & dosage | Disease-Free Survival | Phenylurea Compounds - administration & dosage | Asia | Protein Kinase Inhibitors - therapeutic use | Carcinoma, Hepatocellular - pathology | Aged | Australia | Antimitotic agents | Liver cancer | Medical colleges | Surgery | Liver | Clinical trials | Hepatoma | Antineoplastic agents | Index Medicus
Journal Article